Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pulse Biosciences, Inc - Common Stock (NQ:PLSE)

16.79 +1.69 (+11.19%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 362,408
Open 15.30
Bid (Size) 16.77 (1)
Ask (Size) 17.25 (5)
Prev. Close 15.10
Today's Range 15.19 - 17.06
52wk Range 13.77 - 25.00
Shares Outstanding 54,902,942
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Pulse Biosciences Cash Jumps in Q2
Via The Motley Fool
Topics Intellectual Property
Pulse Biosciences Inc (NASDAQ:PLSE) Reports Q2 2025 Earnings: Wider Loss, Clinical Progress in Focus
Pulse Biosciences reported a Q2 2025 net loss of $0.28 per share, slightly wider than estimates, with no revenue. The company advances its nsPFA tech in clinical trials, focusing on atrial fibrillation... 
Via Chartmill

Performance

YTD
-5.6%
-5.6%
1 Month
+4.5%
+4.5%
3 Month
-0.3%
-0.3%
6 Month
-22.4%
-22.4%
1 Year
+7.3%
+7.3%

More News

Read More
Pulse Biosciences Reports Business Updates and Second Quarter 2025 Financial Results
From Pulse Biosciences, Inc.
Via Business Wire
Pulse Biosciences To Present at the 45th Canaccord Genuity Annual Growth Conference
From Pulse Biosciences, Inc.
Via Business Wire
Earnings Scheduled For May 8, 2025
Via Benzinga
Earnings Scheduled For August 12, 2025
Via Benzinga
Pulse Biosciences Schedules Second Quarter 2025 Business Updates and Financial Results Conference Call for August 12, 2025
From Pulse Biosciences
Via Business Wire
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Pulse Biosciences, Inc.
Via Business Wire
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Pulse Biosciences, Inc.
Via Business Wire
Pulse Biosciences Reports Business Updates and First Quarter 2025 Financial Results
From Pulse Biosciences, Inc.
Via Business Wire
Pulse Biosciences To Present at the BofA Securities 2025 Health Care Conference
From Pulse Biosciences, Inc.
Via Business Wire
Pulse Biosciences’ Nanosecond PFA Technology to be Featured at The American Association for Thoracic Surgery 2025 Annual Meeting
From Pulse Biosciences, Inc.
Via Business Wire
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Pulse Biosciences, Inc.
Via Business Wire
Pulse Biosciences Schedules First Quarter 2025 Financial Results Conference Call for May 8, 2025
From Pulse Biosciences, Inc.
Via Business Wire
Pulse Biosciences’ Nanosecond PFA Technology to be Featured at The Heart Rhythm Society 2025 Annual Meeting
From Pulse Biosciences, Inc.
Via Business Wire
Curious about the stocks that are showing activity after the closing bell on Wednesday?
Via Chartmill
Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2024 Financial Results
From Pulse Biosciences, Inc.
Via Business Wire
Pulse Biosciences To Present at the 24th Annual Needham Virtual Health Care Conference
From Pulse Biosciences, Inc.
Via Business Wire
Earnings Scheduled For March 27, 2025
Via Benzinga
Pulse Biosciences Schedules Fourth Quarter & Full Year 2024 Financial Results Conference Call for March 27, 2025
From Pulse Biosciences, Inc.
Via Business Wire
Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Pulse Biosciences, Inc.
Via Business Wire
Pulse Biosciences To Present at the TD Cowen 45th Annual Health Care Conference
From Pulse Biosciences, Inc.
Via Business Wire
Pulse Biosciences, Inc. Appoints Jon Skinner as Chief Financial Officer
From Pulse Biosciences, Inc.
Via Business Wire
Pulse Biosciences’ Nanosecond PFA Technology to Be Featured in Presentations at North American Society for Interventional Thyroidology Annual Meeting
From Pulse Biosciences, Inc.
Via Business Wire
Pulse Biosciences Announces Late-Breaking Data from its Nanosecond PFA 360° Cardiac Catheter System First-In-Human Feasibility Study Presented at the AF Symposium
From Pulse Biosciences, Inc.
Via Business Wire

Frequently Asked Questions

Is Pulse Biosciences, Inc - Common Stock publicly traded?
Yes, Pulse Biosciences, Inc - Common Stock is publicly traded.
What exchange does Pulse Biosciences, Inc - Common Stock trade on?
Pulse Biosciences, Inc - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Pulse Biosciences, Inc - Common Stock?
The ticker symbol for Pulse Biosciences, Inc - Common Stock is PLSE on the Nasdaq Stock Market
What is the current price of Pulse Biosciences, Inc - Common Stock?
The current price of Pulse Biosciences, Inc - Common Stock is 16.79
When was Pulse Biosciences, Inc - Common Stock last traded?
The last trade of Pulse Biosciences, Inc - Common Stock was at 08/13/25 04:00 PM ET
What is the market capitalization of Pulse Biosciences, Inc - Common Stock?
The market capitalization of Pulse Biosciences, Inc - Common Stock is 921.82M
How many shares of Pulse Biosciences, Inc - Common Stock are outstanding?
Pulse Biosciences, Inc - Common Stock has 922M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.